Survival statistics for Hodgkin lymphoma
Survival statistics for Hodgkin lymphoma (HL) are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for HL and what they mean to you.
Net survival represents the probability of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive their cancer.
In Canada, the 5-year net survival for Hodgkin lymphoma is 85%. This means that, on average, about 85% of people diagnosed with Hodgkin lymphoma will survive for at least 5 years.
Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer, but who share similar characteristics (such as age and sex).
Survival by stage
Survival varies with each stage of HL. The following factors can also affect survival for HL.
- Generally, the earlier HL is diagnosed and treated, the better the outcome.
- Low tumour bulk results in a better outcome.
- The absence of B symptoms results in a better outcome.
- Overall, HL is very responsive to treatment.
|Stage||5-year relative survival|
The International Prognostic Factors Project (IPFP) has developed an international prognostic score (IPS) for advanced disease (stage III and IV) based on adverse risk factors that are present at the time of diagnosis.
- 60% to 80% of people with advanced favourable disease (0–3 adverse risk factors) are relapse-free (cancer has not come back) 5 years after treatment.
- 42% to 51% of people with advanced unfavourable disease (4 or more adverse risk factors) are relapse-free 5 years after treatment.
Questions about survival
Talk to your doctor about your prognosis. A prognosis depends on many factors, including:
- your health history
- the type of cancer
- the stage
- certain characteristics of the cancer
- the treatments chosen
- how the cancer responds to treatment
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.
Investing to reduce cancer burden
Last year CCS funded $40 million in cancer research, thanks to our donors. Discover how you can help reduce the burden of cancer.